Dr Reddys Laboratories Share Price Today - Live Blog for June 26, 2025

Dr Reddys Laboratories Ltd's share price has fallen by -0.02%, a situation worth noting. At present, the stock is trading at ₹1,320.20. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.7900, while the industry PE ratio is 34.2321.

Dr Reddys Laboratories Ltd witnessed a substantial 0.03% increase in its share price and is currently trading at ₹1,320.85. This remarkable performance has caught the eye of investors.

Following a noteworthy 0.10% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,320.40. When it comes to valuation, this stock has a PE ratio of 19.7900, with the industry PE ratio at 34.2321.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.09% recently. As of now, this stock is actively trading at a current market price of ₹1,319.80 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd witnessed a notable 0.05% surge in its share price and is presently trading at ₹1,319.10, captivating the attention of market participants.

Dr Reddys Laboratories Ltd shares experienced a -0.01% reduction, with the current market price at ₹1,319.25. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The stock of Dr Reddys Laboratories Ltd suffered a -0.11% decline, and it currently trades at ₹1,318.70 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd experienced a -0.01% dip in its share price and is currently trading at ₹1,319.00. The stock has a PE ratio of 19.7900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's shares experienced a 0.08% uptick, and they are currently valued at ₹1,319.10, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd share price surged by 0.06%. With its current market price standing at ₹1,318.25 per share, this stock is garnering increased attention from the investment community.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.27% recently. As of now, this stock is actively trading at a current market price of ₹1,318.70 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.15%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,315.20, and market participants are assessing the implications. The stock has a PE ratio of 19.7900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a -0.04% drop in its share price and is currently trading at ₹1,318.05. With the stock's PE at 19.7900 and the industry PE at 34.2321, investors are weighing their options.

Dr Reddys Laboratories Ltd's stock price surged by 0.19%, reaching the current market value of ₹1,318.55 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.08% uptick in its share price. As a result, it's now actively trading at ₹1,316.05 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd witnessed a notable 0.08% surge in its share price and is presently trading at ₹1,316.05, captivating the attention of market participants.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.08%. At this moment, it's actively trading at ₹1,316.05, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd share price has declined by -0.01%, and it's currently trading at ₹1,318.00. The stock maintains a PE of 19.7900, while the industry PE is 34.2321, prompting discussions about its valuation.

After a significant 0.05% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,318.10 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.19%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,317.45, and market participants are assessing the implications. The stock has a PE ratio of 19.7900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a notable 0.06% surge in its share price and is presently trading at ₹1,320.00, captivating the attention of market participants.

The stock of Dr Reddys Laboratories Ltd suffered a -0.26% drop, and it's now trading at ₹1,319.10 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.08%, reaching the current market price of ₹1,324.00. This development underscores the stock's growing popularity.

The stock of Dr Reddys Laboratories Ltd suffered a -0.25% decline, and it currently trades at ₹1,323.20 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd stock price decreased by -0.21%, with the current market value at ₹1,322.40 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Dr Reddys Laboratories Ltd is facing a -0.50% decline and is currently trading at ₹1,324.70 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The stock of Dr Reddys Laboratories Ltd has experienced a -1.26% drop, and it's now trading at ₹1,327.95 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.